We are live on ! Find out more
RLYB icon

Rallybio
RLYB

59 hedge funds and large institutions have $188M invested in Rallybio in 2023 Q2 according to their latest regulatory filings, with 11 funds opening new positions, 23 increasing their positions, 10 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

130% more repeat investments, than reductions

Existing positions increased: 23 | Existing positions reduced: 10

120% more first-time investments, than exits

New positions opened: 11 | Existing positions closed: 5

11% more funds holding

Funds holding: 53 → 59 (+6)

3% more capital invested

Capital invested by funds: $183M → $188M (+$4.87M)

0.47% more ownership

Funds ownership: 10.54% → 11.01% (+0.47%)

0% more funds holding in top 10

Funds holding in top 10: 4 → 4 (0)

Holders
59
Holders Change
+6
Holders Change %
+11.32%
% of All Funds
0.93%
Holding in Top 10
4
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.06%
New
11
Increased
23
Reduced
10
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
BlackRock
BlackRock
New York
+$4.42M
2
Mariner
Mariner
Kansas
+$3.6M
3
State Street
State Street
Massachusetts
+$1.34M
4
Geode Capital Management
Geode Capital Management
Massachusetts
+$794K
5
Northern Trust
Northern Trust
Illinois
+$419K

Top Sellers

1
CA
CHI Advisors
New York
-$1.33M
2
SAM
Sectoral Asset Management
Quebec, Canada
-$1.08M
3
Vontobel Holding
Vontobel Holding
Switzerland
-$1M
4
CCM
CAAS Capital Management
New York
-$814K
5
NHAS
Novo Holdings A/S
Denmark
-$503K
Name Holding Trade Value Shares
Change 		Change in
Stake
Viking Global Investors
1
Viking Global Investors
Connecticut
$23.7M – – –
5VM
2
5AM Venture Management
California
$20.5M – – –
NLVP
3
New Leaf Venture Partners
New York
$18.7M – – –
Fidelity Investments
4
Fidelity Investments
Massachusetts
$18.4M +$2.79K +57 +0%
TGA
5
TPG GP A
Texas
$17.1M – – –
PBPIA
6
Pivotal bioVenture Partners Investment Advisor
California
$13.6M – – –
NHAS
7
Novo Holdings A/S
Denmark
$12.4M -$503K -10,264 -4%
CPX
8
Canaan Partners XI
California
$11.7M – – –
TCM
9
Tekla Capital Management
Massachusetts
$9.78M – – –
BlackRock
10
BlackRock
New York
$9.36M +$4.42M +90,295 +78%
Vanguard Group
11
Vanguard Group
Pennsylvania
$5.88M +$264K +5,387 +4%
LCM
12
Laurion Capital Management
New York
$4.43M – – –
Mariner
13
Mariner
Kansas
$3.43M +$3.6M +73,570 +3,284%
CA
14
CHI Advisors
New York
$3.07M -$1.33M -27,221 -29%
Geode Capital Management
15
Geode Capital Management
Massachusetts
$2.79M +$794K +16,201 +36%
State Street
16
State Street
Massachusetts
$2.79M +$1.34M +27,386 +80%
SAM
17
Sectoral Asset Management
Quebec, Canada
$2.13M -$1.08M -21,997 -32%
Citadel Advisors
18
Citadel Advisors
Florida
$1.67M -$355K -7,244 -16%
VA
19
VR Adviser
New York
$1.52M – – –
Northern Trust
20
Northern Trust
Illinois
$1.26M +$419K +8,551 +44%
Bank of New York Mellon
21
Bank of New York Mellon
New York
$513K +$241K +4,921 +77%
Charles Schwab
22
Charles Schwab
California
$436K +$137K +2,795 +41%
N
23
Nuveen
North Carolina
$350K +$239K +4,877 +171%
Goldman Sachs
24
Goldman Sachs
New York
$261K +$156K +3,185 +124%
RhumbLine Advisers
25
RhumbLine Advisers
Massachusetts
$216K +$92.4K +1,885 +65%
1
2 3

RLYB Hedge Fund Activity: Q2 2023 in Review

59 of the 6,369 institutional investors tracked by Wall St. Rank reported a position in Rallybio (RLYB) for Q2 2023, worth a combined $188M — up 2.7% from $183M a quarter earlier.

Buyers outnumbered sellers: 11 funds opened new RLYB positions and 5 closed out — a net gain of 6 holders — while 23 added to existing stakes and 10 trimmed.

The largest buyer was BlackRock, adding an estimated $4.42M. The largest seller was CHI Advisors, cutting an estimated $1.33M.

  • 59 institutional investors held Rallybio (RLYB) as of Q2 2023, up from 53 in Q1 2023.
  • Funds reported $188M of Rallybio stock for Q2 2023, up 2.7% quarter-over-quarter.
  • 11 funds opened new Rallybio positions in Q2 2023 and 5 closed out, a net change of +6 holders.
  • The largest Rallybio buyer in Q2 2023 was BlackRock, an estimated $4.42M added.
  • The largest Rallybio seller in Q2 2023 was CHI Advisors, an estimated $1.33M sold.

Based on aggregated 13F filings for Q2 2023.